These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32892663)

  • 41. Pharmacologic treatment options for prediabetes.
    Hsueh WA; Handelsman Y
    Nat Clin Pract Endocrinol Metab; 2008 Jul; 4(7):380-1. PubMed ID: 18523427
    [No Abstract]   [Full Text] [Related]  

  • 42. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
    ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
    Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Approach to the patient with prediabetes.
    Aroda VR; Ratner R
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3259-65. PubMed ID: 18772457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes.
    Luo Y; Paul SK; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Wang H
    J Diabetes Res; 2017; 2017():7602408. PubMed ID: 28168204
    [No Abstract]   [Full Text] [Related]  

  • 45. Current and emerging pharmacotherapy for prediabetes: are we moving forward?
    Mangan A; Docherty NG; Le Roux CW; Al-Najim W
    Expert Opin Pharmacother; 2018 Oct; 19(15):1663-1673. PubMed ID: 30198813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of prediabetes.
    Priya G
    J Pak Med Assoc; 2018 Apr; 68(4):669-671. PubMed ID: 29808066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liraglutide Therapy in a Prediabetic State: Rethinking the Evidence.
    Papaetis GS
    Curr Diabetes Rev; 2020; 16(7):699-715. PubMed ID: 31886752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of incretin-based therapies in prediabetes: a review.
    Ahmadieh H; Azar ST
    Prim Care Diabetes; 2014 Dec; 8(4):286-94. PubMed ID: 24666932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metformin in Prevention of Type 2 Diabetes.
    Snehalatha C; Priscilla S; Nanditha A; Arun R; Satheesh K; Ramachandran A
    J Assoc Physicians India; 2018 Mar; 66(3):60-3. PubMed ID: 30341871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.
    Cefalu WT; Buse JB; Tuomilehto J; Fleming GA; Ferrannini E; Gerstein HC; Bennett PH; Ramachandran A; Raz I; Rosenstock J; Kahn SE
    Diabetes Care; 2016 Jul; 39(7):1186-201. PubMed ID: 27631469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediabetes Screening and Treatment in Diabetes Prevention: The Impact of Physician Attitudes.
    Mainous AG; Tanner RJ; Scuderi CB; Porter M; Carek PJ
    J Am Board Fam Med; 2016 Nov; 29(6):663-671. PubMed ID: 28076248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obesity and type 2 diabetes: which patients are at risk?
    Garber AJ
    Diabetes Obes Metab; 2012 May; 14(5):399-408. PubMed ID: 22074144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patterns of Diabetes Screening and Prediabetes Treatment during Office Visits in the US.
    Shealy KM; Wu J; Waites J; Taylor NA; Blair Sarbacker G
    J Am Board Fam Med; 2019; 32(2):209-217. PubMed ID: 30850457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Inquiries: How can we keep impaired glucose tolerance and impaired fasting glucose from progressing to diabetes?
    Swanson A; Watrin K; Wilder L
    J Fam Pract; 2010 Sep; 59(9):532-3. PubMed ID: 20824232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.
    Palmer AJ; Roze S; Valentine WJ; Spinas GA; Shaw JE; Zimmet PZ
    Clin Ther; 2004 Feb; 26(2):304-21. PubMed ID: 15038953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Should Adults with Prediabetes Be Prescribed Metformin to Prevent Diabetes Mellitus? Yes: High-Quality Evidence Supports Metformin Use in Persons at High Risk.
    Moin T
    Am Fam Physician; 2019 Aug; 100(3):134-135. PubMed ID: 31361108
    [No Abstract]   [Full Text] [Related]  

  • 57. Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study.
    Chukir T; Mandel L; Tchang BG; Al-Mulla NA; Igel LI; Kumar RB; Waitman J; Aronne LJ; Shukla AP
    Obes Res Clin Pract; 2021; 15(1):64-68. PubMed ID: 33386253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PREVENT-DM Comparative Effectiveness Trial of Lifestyle Intervention and Metformin.
    O'Brien MJ; Perez A; Scanlan AB; Alos VA; Whitaker RC; Foster GD; Ackermann RT; Ciolino JD; Homko C
    Am J Prev Med; 2017 Jun; 52(6):788-797. PubMed ID: 28237635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Recent advances in pharmacological intervention for prediabetes].
    Lan JQ; Zhu CJ
    Yao Xue Xue Bao; 2015 Dec; 50(12):1565-72. PubMed ID: 27169278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
    Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.